TGFB1 and arthritic joint disease: Anti-TGF-β and anti-TGF-βRI antibodies injection inhibits chronic synovial inflammation in rats with streptococcal cell wall-induced arthritis [33] and in antigen- and collagen-induced arthritis mice [34].